Literature DB >> 8452781

Radiation therapy in the management of cancer of the cervix.

C A Perez1.   

Abstract

In general, reported 5-year survival rates are 85% to 90% for stage IB, about 75% for stage IIA, 60% to 65% for IIB, 25% to 50% for stage IIIB, and 10% or less for stage IV. For bulky lesions, a combination of preoperative irradiation and hysterectomy has been tried; however, in some studies the results are no better than those noted with higher doses of irradiation alone.

Entities:  

Mesh:

Year:  1993        PMID: 8452781

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  2 in total

1.  The efficacy of concurrent cisplatin and 5-flurouracil chemotherapy and radiation therapy for locally advanced cancer of the uterine cervix.

Authors:  Il Jung Choi; Moon Seok Cha; Eunku Seul Park; Myung Seok Han; Youngmin Choi; Goo Hwa Je; Hyun Ho Kim
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

2.  Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer.

Authors:  Tae Wook Kong; Suk-Joon Chang; Jiheum Paek; Seung-Chul Yoo; Jong-Hyuck Yoon; Ki-Hong Chang; Mison Chun; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.